Notice of Change in Application Types Allowed for PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)

Notice Number: NOT-AG-20-019

Key Dates
Release Date: March 3, 2020

Related Announcements
PAR-19-071

Issued by
National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants that the application types allowed in response to PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Not Allowed) have been expanded to include Revision and Resubmission applications. This change is effective as of the July 9, 2020 application due date.

Current language:

Part 2. Section II. Award Information

Application Types Allowed: New

Part 2. Section V. Application Review Information, Additional Review Criteria

Resubmissions

Not Applicable

Revisions

Not Applicable

Modified to read:

Part 2. Section II. Award Information

Application Types Allowed: New, Resubmission, Revision

Part 2. Section V. Application Review Information, Additional Review Criteria

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Revisions

For Revisions, the committee will consider the appropriateness of the proposed expansion of the scope of the project. If the Revision application relates to a specific line of investigation presented in the original application that was not recommended for approval by the committee, then the committee will consider whether the responses to comments from the previous scientific review group are adequate and whether substantial changes are clearly evident.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Kenneth Santora, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email: kenneth.santora@nih.gov